Yilong Ma

Overview

Best Publications

• Correction for Partial Volume Effects in PET: Principle and Validation

  Olivier G. Rousset;Yilong Ma;Alan C. Evans

  1134
  Citations

• Changes in network activity with the progression of Parkinson's disease.

  Chaorui Huang;Chengke Tang;Andrew Feigin;Martin Lesser

  451
  Citations

• Network modulation in the treatment of Parkinson's disease.

  Kotaro Asanuma;Kotaro Asanuma;Chengke Tang;Chengke Tang;Yilong Ma;Yilong Ma;Vijay Dhawan;Vijay Dhawan

  403
  Citations

• Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

  Yilong Ma;Yilong Ma;Chengke Tang;Chengke Tang;Phoebe G Spetsieris;Phoebe G Spetsieris;Vijay Dhawan;Vijay Dhawan

  352
  Citations

• Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.

  Yilong Ma;Yilong Ma;Andrew Feigin;Andrew Feigin;Vijay Dhawan;Vijay Dhawan;Masafumi Fukuda

  303
  Citations

• Parkinson’s Disease Tremor-Related Metabolic Network: Characterization, Progression, and Treatment Effects

  Hideo Mure;Shigeki Hirano;Chris C. Tang;Chris C. Tang;Ioannis U. Isaias

  302
  Citations

• Parkinsonism and Related Disorders

  Ping Wu;Jian Wang;Shichun Peng;Yilong Ma

  276
  Citations

• Thalamic metabolism and symptom onset in preclinical Huntington's disease.

  A. Feigin;C. Tang;Y. Ma;P. Mattis

  223
  Citations

• Abnormal metabolic networks in atypical parkinsonism.

  Thomas Eckert;Thomas Eckert;Chengke Tang;Yilong Ma;Yilong Ma;Nathaniel Brown

  212
  Citations

• Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes

  Yilong Ma;Chengke Tang;Thomas Chaly;Paul Greene

  212
  Citations

• Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease

  Maja Trošt;Sherwin Su;Philip Su;Ruoh-Fang Yen

  207
  Citations

• Abnormal metabolic network activity in REM sleep behavior disorder

  Florian Holtbernd;Jean-François Gagnon;Ron B. Postuma;Yilong Ma

  178
  Citations

• Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.

  M. Fukuda;M. J. Mentis;M. J. Mentis;Y. Ma;Y. Ma;V. Dhawan;V. Dhawan

  177
  Citations

• Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation

  K. Asanuma;Y. Ma;J. Okulski;V. Dhawan

  172
  Citations

• Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.

  Ping Wu;Huan Yu;Shichun Peng;Yves Dauvilliers

  162
  Citations

• Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.

  Marina E Emborg;Maren Carbon;James E Holden;Matthew J During

  161
  Citations

• Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.

  M. Carbon;M. Niethammer;S. Peng;D. Raymond

  155
  Citations

• Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

  Shigeki Hirano;Kotaro Asanuma;Yilong Ma;Chengke Tang

  149
  Citations

• Metabolic network as a progression biomarker of premanifest Huntington’s disease

  Chris C. Tang;Andrew Feigin;Yilong Ma;Christian Habeck

  148
  Citations

• Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.

  Unknown

  143
  Citations

• Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

  Maren Carbon;Yilong Ma;Anna Barnes;Vijay Dhawan

  139
  Citations

• Effects of serotonin transporter promoter polymorphisms on serotonin function.

  Gwenn S Smith;Francis E Lotrich;Anil K Malhotra;Annette T Lee

  138
  Citations